
Manpreazy
10.6K posts

Manpreazy
@Manpreazy
market trader - family - athlete - A goal without a plan is a wish #MSOgang #TrimtheRip #oott





A federal judge has dismissed a lawsuit led by prohibitionist group Smart Approaches to Marijuana (SAM) challenging the Trump administration’s Medicare-linked CBD program, finding the plaintiffs failed to show they had standing to bring the case. themarijuanaherald.com/2026/05/federa…

Putting this down as the news of the morning. TSA updates its policies to allow medical marijuana in checked and carry-on bags. tsa.gov/travel/securit…

I really really want to partner with THC / weed brands . Plz lmk here with any

HIVE Digital Technologies $HIVE announced plans to develop a 320MW AI data centre in the Greater Toronto Area through Buzz HPC, targeting more than 100,000 GPUs and operations beginning in H2 2027. The proposed “AI gigafactory” represents a planned C$3.5B investment aimed at expanding Canada’s domestic AI infrastructure capacity. finance.yahoo.com/sectors/techno…

1/ Missed $DGXX? I got you covered. A similar setup fundamentally and technically: $HIVE. Stock at $2.82. 52 week low. Market cap ~$500M. Won't happen overnight. But the ingredients are there. 🧵




Only 5 generational buying opportunities for $MSFT in the last 26 years...


@HoddinottJustin @c2412345 The "all-clear" for uplisting to the NYSE will happen in Q4 if hearing results are ✅. Maybe Congress expedites the finally ruling via the CLIMB Act. I’m guessing $ will start front running & once uplisting is done, flood gates open up 🤷



They are all super mis-priced. I feel like $vrnof $Vrno is the most mis-priced from the bunch 🤷 $gtbif $tcnnf $curlf $crlbf $msos


The market still doesn’t fully appreciate how much protected, recurring medical revenue the top MSOs have built. Adult-use gets the headlines, but medical is still the cash flow backbone — and if 280E relief or rescheduling hits, the companies with the largest medical exposure could see margins re-rate fast. Approximate medical-heavy revenue exposure among the top MSOs: • Trulieve — ~$900M+ medical-focused revenue (Florida dominance still matters) • Curaleaf — ~$700M–$800M medical exposure across key states • Green Thumb Industries — ~$500M+ medical revenue with strongest balance sheet in sector • Verano Holdings — ~$450M–$550M medical-heavy revenue mix • Cresco Labs — ~$350M–$450M tied to medical and wholesale channels Everyone talks about legalization upside. Hardly anyone talks about what happens when billions of already-existing medical revenue becomes materially more profitable overnight. That’s the real setup. Based on my best analysis that i could find. @Trulieve @GTIGrows @crescolabs @veranobrands @Curaleaf_Inc



re: Carney's (expected) Methane emissions cuts: 🏆 $TOU.TO / @TourmalineOil "is the first company in the world to have its integrated #NaturalGas production system independently certified under MiQ’s methane emissions standard". Read the PR. miq.org/canadas-larges…











